Biogened Statistics
Total Valuation
Biogened has a market cap or net worth of PLN 75.16 million. The enterprise value is 94.41 million.
Market Cap | 75.16M |
Enterprise Value | 94.41M |
Important Dates
The last earnings date was Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | Sep 12, 2024 |
Share Statistics
Biogened has 2.46 million shares outstanding.
Current Share Class | 2.46M |
Shares Outstanding | 2.46M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 1.17% |
Float | 144,714 |
Valuation Ratios
The trailing PE ratio is 15.73.
PE Ratio | 15.73 |
Forward PE | n/a |
PS Ratio | 0.66 |
PB Ratio | 1.77 |
P/TBV Ratio | 1.79 |
P/FCF Ratio | 18.51 |
P/OCF Ratio | 9.89 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.77, with an EV/FCF ratio of 23.24.
EV / Earnings | 19.75 |
EV / Sales | 0.83 |
EV / EBITDA | 6.77 |
EV / EBIT | 9.76 |
EV / FCF | 23.24 |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.57.
Current Ratio | 2.10 |
Quick Ratio | 1.18 |
Debt / Equity | 0.57 |
Debt / EBITDA | 1.73 |
Debt / FCF | 5.93 |
Interest Coverage | 3.89 |
Financial Efficiency
Return on equity (ROE) is 11.91% and return on invested capital (ROIC) is 9.52%.
Return on Equity (ROE) | 11.91% |
Return on Assets (ROA) | 6.86% |
Return on Invested Capital (ROIC) | 9.52% |
Return on Capital Employed (ROCE) | 15.23% |
Revenue Per Employee | 514,398 |
Profits Per Employee | 21,528 |
Employee Count | 222 |
Asset Turnover | 1.30 |
Inventory Turnover | 1.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.50% in the last 52 weeks. The beta is 0.37, so Biogened's price volatility has been lower than the market average.
Beta (5Y) | 0.37 |
52-Week Price Change | +27.50% |
50-Day Moving Average | 27.58 |
200-Day Moving Average | 24.26 |
Relative Strength Index (RSI) | 56.34 |
Average Volume (20 Days) | 43 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biogened had revenue of PLN 114.20 million and earned 4.78 million in profits.
Revenue | 114.20M |
Gross Profit | 79.26M |
Operating Income | 9.67M |
Pretax Income | 7.13M |
Net Income | 4.78M |
EBITDA | 13.94M |
EBIT | 9.67M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 4.85 million in cash and 24.09 million in debt, giving a net cash position of -19.25 million or -7.84 per share.
Cash & Cash Equivalents | 4.85M |
Total Debt | 24.09M |
Net Cash | -19.25M |
Net Cash Per Share | -7.84 |
Equity (Book Value) | 42.36M |
Book Value Per Share | n/a |
Working Capital | 30.50M |
Cash Flow
In the last 12 months, operating cash flow was 7.60 million and capital expenditures -3.54 million, giving a free cash flow of 4.06 million.
Operating Cash Flow | 7.60M |
Capital Expenditures | -3.54M |
Free Cash Flow | 4.06M |
FCF Per Share | 1.65 |
Margins
Gross margin is 69.41%, with operating and profit margins of 8.47% and 4.19%.
Gross Margin | 69.41% |
Operating Margin | 8.47% |
Pretax Margin | 6.25% |
Profit Margin | 4.19% |
EBITDA Margin | 12.20% |
EBIT Margin | 8.47% |
FCF Margin | 3.56% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.63%.
Dividend Per Share | 0.50 |
Dividend Yield | 1.63% |
Dividend Growth (YoY) | 25.00% |
Years of Dividend Growth | 3 |
Payout Ratio | 25.70% |
Buyback Yield | n/a |
Shareholder Yield | 1.63% |
Earnings Yield | 6.36% |
FCF Yield | 5.40% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |